REGENTS OF THE UNIVERSITY OF CALIFORNIA Cuts Portfolio Down to Size in 4th Quarter

REGENTS OF THE UNIVERSITY OF CALIFORNIA recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.

The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.

1111 BROADWAY OAKLAND, CA 94607-4026

As of the latest 13F report, the guru’s equity portfolio contained 34 stocks valued at a total of $527.00Mil. The top holdings were

According to GuruFocus data, these were REGENTS OF THE UNIVERSITY OF CALIFORNIA’s top five trades of the quarter.

ironSource Ltd


The guru sold out of their 3,442,629-share investment in NYSE:IS. Previously, the stock had a 2.4% weight in the equity portfolio. Shares traded for an average price of $3.29 during the quarter.

On 02/02/2023, ironSource Ltd traded for a price of $2.74 per share and a market cap of $2.81Bil. The stock has returned -75.77% over the past year.

GuruFocus gives the company a financial strength rating of 9 out of 10 and a profitability rating of 5 out of 10.

In terms of valuation, ironSource Ltd has a price-earnings ratio of 45.67, a price-book ratio of 2.37, a EV-to-Ebitda ratio of 20.60 and a price-sales ratio of 4.42.

RAPT Therapeutics Inc


REGENTS OF THE UNIVERSITY OF CALIFORNIA reduced their investment in NAS:RAPT by 83,537 shares. The trade had a 0.41% impact on the equity portfolio. During the quarter, the stock traded for an average price of $20.01.

On 02/02/2023, RAPT Therapeutics Inc traded for a price of $28.26 per share and a market cap of $959.85Mil. The stock has returned 34.70% over the past year.

GuruFocus gives the company a financial strength rating of 6 out of 10. There is insufficient data to calculate the stock’s profitability rating.

In terms of valuation, RAPT Therapeutics Inc has a price-book ratio of 4.46, a EV-to-Ebitda ratio of -10.38 and a price-sales ratio of 361.31.

The price-to-GF Value ratio is 3.66, earning the stock a GF Value rank of 1.

Advanced Drainage Systems Inc


The guru sold out of their 10,482-share investment in NYSE:WMS. Previously, the stock had a 0.26% weight in the equity portfolio. Shares traded for an average price of $101.34 during the quarter.

On 02/02/2023, Advanced Drainage Systems Inc traded for a price of $86.44 per share and a market cap of $7.16Bil. The stock has returned -24.71% over the past year.

GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 7 out of 10.

In terms of valuation, Advanced Drainage Systems Inc has a price-earnings ratio of 15.95, a price-book ratio of 5.99, a price-earnings-to-growth (PEG) ratio of 0.93, a EV-to-Ebitda ratio of 11.71 and a price-sales ratio of 2.14.

The price-to-GF Value ratio is 0.73, earning the stock a GF Value rank of 9.

HashiCorp Inc


The guru sold out of their 31,170-share investment in NAS:HCP. Previously, the stock had a 0.2% weight in the equity portfolio. Shares traded for an average price of $28.3 during the quarter.

On 02/02/2023, HashiCorp Inc traded for a price of $37.28 per share and a market cap of $7.01Bil. The stock has returned -45.74% over the past year.

GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 1 out of 10.

In terms of valuation, HashiCorp Inc has a price-book ratio of 5.80, a EV-to-Ebitda ratio of -10.98 and a price-sales ratio of 15.72.

Berkshire Hathaway Inc


REGENTS OF THE UNIVERSITY OF CALIFORNIA reduced their investment in NYSE:BRK.B by 2,320 shares. The trade had a 0.13% impact on the equity portfolio. During the quarter, the stock traded for an average price of $296.98.

On 02/02/2023, Berkshire Hathaway Inc traded for a price of $311.86 per share and a market cap of $688.06Bil. The stock has returned -2.32% over the past year.

GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 8 out of 10.

In terms of valuation, Berkshire Hathaway Inc has a price-book ratio of 1.52, a EV-to-Ebitda ratio of 69.14 and a price-sales ratio of 2.74.

The price-to-GF Value ratio is 1.15, earning the stock a GF Value rank of 3.


Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.

When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.

Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!

This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.